Thomas Ciesielski, MD, an associate professor in the Division of General Internal Medicine in the John T. Milliken Department of Medicine at WashU Medicine, has been named the 2026–27 Presidential Fellow in Healthcare Safety and Quality by Joint Commission. The prestigious fellowship recognizes a distinguished professional who is ascending in a career dedicated to advancing […]
The halls of Washington University School of Medicine were filled with familiar faces and a shared sense of history this past April as the Department of Dermatology welcomed back a vibrant community of alumni, former residents, and faculty for the 2026 Alumni Weekend.
Nathan Stitziel, MD, PhD, professor of medicine and genetics at WashU Medicine, has received $1.9 million over five years from the Leducq Foundation as part of an international Network of Excellence award to identify genetic pathways that drive atherosclerosis and uncover new strategies to prevent heart attacks and strokes.
William Bowen Professor of Medicine and Professor of Public Health Mark Huffman, MD, MPH, has been appointed to the advisory board of the Fogarty International Center at the National Institutes of Health (NIH). Huffman received the invitation from U.S. Secretary of Health and Human Services Robert F. Kennedy Jr.
The Centers for Disease Control and Prevention is working with state and federal partners to investigate several outbreaks of cyclosporiasis, a gastrointestinal disease caused by the microscopic parasite Cyclospora cayetanensis. In a health alert published July 14, the CDC reported 1,645 known cases of cyclosporiasis nationwide May to July of 2026.
The American Society for Bone and Mineral Research (ASBMR) released the 2026 Esteemed Awardees and has named Erica L. Scheller, DDS, PhD, as the recipient of the prestigious 2026 Fuller Albright Award. Named after Dr. Fuller Albright, a pioneer in parathyroid and osteoporosis research, this award recognizes scientific achievement by an investigator relatively early in […]
Deborah J. Lenschow, MD, PhD, a pioneering scientist who has made significant contributions to the fields of immunology, rheumatology and medicine, has been installed as the inaugural John S. Daniels Professor at WashU Medicine.
Six individuals whose work has transformed patient care, advanced scientific discovery, strengthened medical education and expanded WashU Medicine’s impact around the world have been honored with the 2026 Dean’s Medals. The annual awards recognize extraordinary contributions to WashU Medicine and celebrate leaders whose achievements embody the institution’s interconnected missions of patient care, education and research.
The Division of Pulmonary & Critical Care Medicine is pleased to congratulate Tom Brett, PhD, and Jennifer Alexander-Brett, MD, PhD, on receiving an award from The Michael J. Fox Foundation for Parkinson’s Research in support of their project, Investigating and Targeting TREM2 in Cellular PD Assays.
Jeffrey Millman, PhD, Alan A. and Edith L. Wolff Professor of Endocrinology and Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, has received new research funding to further his groundbreaking diabetes research.
A newly defined liver disease linked to alcohol consumption and obesity is surging, drawing significant concern among health experts and federal officials as common risk factors increasingly collide.
Michael S. Diamond, MD, PhD, the Herbert S. Gasser Professor in the Departments of Medicine, Molecular Microbiology, and Pathology & Immunology, has been honored with multiple rankings and awards among the world’s top scientists by Research.com, including No. 10 in the world among the Best Scientists for 2026 in Microbiology.
Maria S. Remedi, PhD, Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, is the senior author of an article published February 9, 2026, in MedComm (Volume 7, Issue 2).
Faculty, residents, fellows, students, and trainees from WashU Medicine’s Division of Dermatology joined researchers and clinicians in Chicago this spring for the annual meeting of the Society for Investigative Dermatology (SID), one of the leading conferences dedicated to advancing skin biology and dermatologic research.
The bacteria enterotoxigenic E. coli and Shigella together cause hundreds of millions of infections each year and are among the leading causes of diarrheal death, especially in children. Decades of vaccine development efforts have come up short, in part because the usual vaccine targets vary too much from one strain to the next.
ST. LOUIS, Mo. (First Alert 4) -A cutting-edge procedure for treating sickle cell disease is changing lives in the St. Louis area, where an estimated 1,200 people have the debilitating blood disorder. Damon Williams, 48, is the first adult patient in the St. Louis region to receive a new gene therapy treatment for sickle cell […]
The Americans with Disabilities Act (ADA) became law on July 26, 1990 and was signed by President George H.W. Bush. In his remarks, President George H. W. Bush famously said, “And now I sign legislation which takes a sledgehammer to another wall, one which has for too many generations separated Americans with disabilities from the […]
Lead author Clair Crewe, PhD, Assistant Professor of Medicine in WashU Medicine’s Division of Cell Biology and Physiology and Division of Endocrinology, Metabolism and Lipid Research, the Crewe Lab and collaborators from the Department of Pathology and Immunology and the Center for Human Nutrition are authors of a study published May 5, 2026, in Cell Metabolism.
Janet S. Lee, MD, a highly regarded physician-scientist in pulmonary and critical care medicine, has been installed as the inaugural Selma and Herman Seldin Distinguished Professor of Medicine at WashU Medicine. The professorship is the second established by the Seldins.
Congratulations to Will Ross, MD, MPH, Alumni Endowed Professor of Medicine, Nephrology, and Associate Dean for Diversity at Washington University School of Medicine, who was honored with the National Kidney Foundation’s (NKF) Award of Excellence at their 75th Anniversary Heroes Awards celebration on March 5, 2026.
Ignacio Portales‑Castillo, MD, assistant professor of medicine in the Division of Nephrology, has been selected for funding in the third round of the George M. O’Brien Kidney Resource Alliance (OKRA) Opportunity Pool Program. He will receive $50,000 in research support for his pilot grant proposal, “Reduce Creatine in Proximal Tubule to Enhance Autophagy and Protect from Renal Injury.”
WashU Medicine’s 2026 Dean’s Impact Awards recognize scientists who probe the most basic elements of life and clinicians who translate those insights into care for patients facing critical health challenges.
Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable co-existence with their hosts. Now, researchers at Washington University School of Medicine in St. Louis have harnessed that biological mechanism for potential human benefit, […]
Jeffrey R. Millman, PhD, Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, has received research funding from Breakthrough T1D to support his project titled “Overcoming Production Barriers to Stem Cell-Islet Therapies Through Scalable Technologies.” The two-year grant supports efforts to address key challenges in bringing manufactured islet cell therapies for type […]
SAN DIEGO, California – VANCOUVER, British Columbia, May 27, 2026 – Phoenix Molecular Designs (PhoenixMD), a clinical-stage precision oncology company developing first-in-class RSK kinase inhibitors, today announced the expansion of its lead asset PMD-026 into a second clinical indication with the initiation of Dauntless-3, an investigator-initiated Phase 1 trial in myelofibrosis at Washington University School […]
Scientists carrying out research on the compound nicotinamide adenine dinucleotide — or simply NAD+ — are running into an unusual problem these days: A little too much publicity around their subject of study.
A routine sports physical changed the course of one young athlete’s life but sparked a new calling.
Congratulations to Zhiyu Dai, PhD, Associate Professor of Medicine, who was selected for the 2026 Werner Risau Early Career Investigator Award in Vascular Biology. This distinguished award was established in honor of Dr. Werner Risau, an investigator who formulated key concepts for the regulation of angiogenesis, challenged the prevailing dogmas about angiogenic factors, and proposed […]
Transplant nephrologist Anuja Java, MD, associate professor of medicine at WashU Nephrology and Director of Kidney Transplant at the John Cochran VA Medical Center, was invited for the third consecutive year to speak at the International Society of Nephrology’s World Congress of Nephrology (WCN’26), held this year, March 28–31, 2026, in Yokohama, Japan.
The National Kidney Foundation (NKF) 2026 Spring Clinical Meetings (SCM) will be held May 6 -10 at the New Orleans Ernest N. Morial Convention Center, bringing together kidney‑care professionals from across the country for practical education, clinical updates, and multidisciplinary collaboration.
Andreas Herrlich, MD, PhD, has been elected a Fellow of the American Association for the Advancement of Science (AAAS), one of the most prestigious honors in the scientific community.
On June 19th, we celebrate Juneteenth, the annual commemoration of the end of slavery in the United States following the Civil War. In Galveston, Texas, on June 19, 1865, Major General Gordon Grander announced the end of the Civil War and that those enslaved were now free. This announcement, however, came two and a half […]
WashU Medicine infectious diseases researchers have developed a practical use of artificial intelligence to enhance patient safety, while potentially reducing costs and improving efficiency at hospitals. Abby Sung, MD, an assistant professor of medicine, and colleagues in the Division of Infectious Diseases, WashU McKelvey School of Engineering AI for Health Institute, and Barnes-Jewish Hospital (BJH) found that a large language model (LLM) can strengthen a semi-automated surveillance tool used by infection prevention.
It’s the leading risk factor for the leading cause of death in the United States and around the world: high blood pressure, the prime mover in heart attacks and strokes.
Throughout the academic year, scholars work relentlessly to elevate their learning and support their peers, mentors show up day after day ready to provide guidance to their mentees, and course directors engage scholars in labs and classrooms with dynamic training. This strong community is central to the success of programs at WashU Medicine, and it […]
What began as a small, hard-to-see mole on Deborah Dieman’s ankle eventually led to a diagnosis of Stage IV melanoma. Despite surgery and standard immunotherapy, her cancer spread aggressively, and she was told she had only months to live.
Nicolo Cabrera, MD, Joseph Cherabie, MD, MSc, and Adriana Rauseo, MD, Assistant Professors of Medicine, and Aaloke Mody, MD, Associate Professor in Medicine, have joined more than a dozen other Washington University School of Medicine Division of Infectious Diseases faculty members as Fellows of the Infectious Diseases Society of America (IDSA). They are among 166 new fellows this year to receive […]
For about an hour, Ariel Hernandez-Leyva held a scientific secret. A discovery only he had uncovered. At the time, more than a decade ago, he was an undergraduate at Yale University, working long hours in a biology lab studying cytokinesis, the final stage of cell division. One spring afternoon, while using a high-resolution fluorescence microscope […]
Congratulations to Dr. Emma Ludwig, who has been named Associate Program Director for the Geriatric Medicine Fellowship in the Division of General Medicine & Geriatrics.
One organ donor can save up to eight lives and improve the lives of more than 75 people through eye and tissue donation. More than 100,000 people are currently on the national transplant waiting list, highlighting the urgent need for donors. For Joseph Wright, that need became personal. “The gift of organ donation allows patients […]
Anne Carol Goldberg, MD, FACP, Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, is a co-author of a study published February 27, 2026, in Nature Medicine. The article, titled “Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial,” explores a potential new option for people living […]
On March 1, Hani Soudah, MD, PhD, Associate Professor of Medicine in the Division of Endocrinology, Metabolism, & Lipid Research at WashU Medicine, along with collaborators, published a new systematic review and meta-analysis examining the broader physiological effects of semaglutide titled “A Systematic Review and Meta-Analysis of Semaglutide Effects on Adipose Tissue and Emerging Effects on Brain and Cognition.”
Irfan Lodhi, PhD, Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, and collaborators are authors of a study published January 8, 2026, in Nature Metabolism. The article, titled “A catecholamine-independent pathway controlling adaptive adipocyte lipolysis,” investigates how the body breaks down stable fat stores during conditions such as starvation, wasting and cachexia.
On May 7, 2026, the Office of Technology Management hosted the ninth annual Celebration of Inventors, an event to honor and recognize Washington University inventors, researchers and faculty entrepreneurs. Honorees included 2025 United States Patent and Trademark Office (USPTO) awardees; newly elected National Academy of Inventors Fellows and Senior Members; and the recipients of the 2026 […]
David Moore is living his best life, thanks to his dedicated team of specialists at WashU Medicine and BJC HealthCare.
Jennifer Alexander‑Brett, MD, PhD, Associate Professor of Medicine, has been featured in a recent Nature Biotechnology article highlighting major advances in targeting interleukin‑33 (IL‑33) signaling in chronic obstructive pulmonary disease (COPD). The article, “Newcomer anti‑IL‑33 makes strides in COPD,” underscores the growing impact of IL‑33–focused therapeutics and the importance of foundational biological insight in translating discovery to patient […]
For highly aggressive types of blood cancer, stem cell transplantation is often the only potentially curative therapy, yet even after a transplant, these cancers often return.
A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people in the U.S., is safe and elicits robust and broad immune responses that appears to increase recurrence-free survival in a subset of patients after surgery, according to an early-stage clinical trial co-led by researchers at Washington University […]
With GLP-1 weight-loss drugs becoming more common, doctors are working to better understand how they affect the body—and what patients can expect beyond weight loss. Dr. Samuel Klein with WashU Medicine is leading a clinical trial exploring those effects, from changes in metabolism and health markers to what happens as people lose significant weight. First […]
A new multinational study finds that individuals with poor mental health consistently report lower-quality healthcare experiences across diverse health systems. Published May 5 in PLOS Medicine, the study was led by Margaret E. Kruk, MD, of Washington University School of Medicine in St. Louis, in collaboration with an international team of researchers.